Exploring the Use of MET Inhibition and Targeted Therapies in Lung Cancer
Roman Perez-Soler, MD, discusses the use of MET inhibitors as treatment of patients with lung cancer and the evolving role of targeted therapy in the lung cancer setting.
MET Target Excites Treatment Paradigm for Patients With Lung Cancer
Roman Perez-Soler, MD, discusses how MET mutations have evolved and impacted the treatment of patients with lung cancer.
Dr. Roman Perez-Soler on Treating NSCLC After First-Line Treatments
Roman Perez-Soler, MD, talks about NSCLC tumors becoming resistance to chemotherapy and first-line treatment.
Challenges Oncologists Face in Treating Lung Cancer
Roman Perez-Soler, MD, chairman and chief, department of medical oncology, Montefiore Medical Center, deputy director, Albert Einstein Cancer Center, discusses the challenges oncologists still face in lung cancer.
